Guangzhou Baiyunshan Pharmaceutical : RESIGNATION OF DIRECTOR

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

(a joint stock company with limited liability established in the People's Republic of China)

(H Share Stock Code: 0874)

RESIGNATION OF DIRECTOR

The board of the directors (the "Board") of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (the "Company") has received the written resignation tendered by Mr. Ni Yidong ("Mr. Ni"), pursuant to which Mr. Ni resigned as an executive director and the member of nomination and remuneration committee of the Company with effect from 22 October 2019 due to job relocation. After resignation, Mr. Ni no longer holds any position in the Company or the Company's subsidiaries.

Mr. Ni has confirmed that he has no disagreement with the Board and there is no other matter that needs to be brought to the attention of the shareholders of the Company in relation to his resignation.

The Board would like to express its sincere gratitude to Mr. Ni for his contributions to the Company during his tenure of office.

The Board of

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited

Guangzhou, the PRC, 22 October 2019

As at the date of this announcement, the Board comprises Mr. Li Chuyuan, Ms. Cheng Ning, Ms. Liu Juyan, Mr. Li Hong, Mr. Wu Changhai and Mr. Zhang Chunbo as executive directors, and Mr. Chu Xiaoping, Mr. Jiang Wenqi, Mr. Wong Hin Wing and Ms. Wang Weihong as independent non- executive directors.